Form 4: Lane Michael reports multiple insider transactions in IDXX

Rhea-AI Filing Summary

Lane Michael reported multiple insider transaction types in a Form 4 filing for IDXX. The filing lists transactions totaling 10,810 shares at a weighted average price of $629.35 per share. Following the reported transactions, holdings were 1,101 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lane Michael

(Last) (First) (Middle)

ONE IDEXX DRIVE

(Street)

WESTBROOK ME 04092

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/14/2026		M		204	A	$0	7,356.944(1)	D
Common Stock	02/14/2026		M		220	A	$0	7,576.944	D
Common Stock	02/14/2026		M		301	A	$0	7,877.944	D
Common Stock	02/14/2026		M		367(2)	A	$0	8,244.944	D
Common Stock	02/14/2026		F		221	D	$629.35(3)	8,023.944(4)	D
Common Stock								592(5)	I	by spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right-to-buy)	$617.2	02/12/2026		A		5,361		(6)	02/11/2036	Common Stock	5,361	$0	5,361	D
Incentive Stock Option (right-to-buy)	$617.2	02/12/2026		A		162		(7)	02/11/2036	Common Stock	162	$0	162	D
Restricted Stock Unit	(8)	02/12/2026		A		1,262		(8)	(8)	Common Stock	1,262	$0	1,262	D
Restricted Stock Unit	(9)	02/12/2026		A		1,620		(9)	(9)	Common Stock	1,620	$0	1,620	D
Restricted Stock Unit	(10)	02/14/2026		M			367	(10)	(10)	Common Stock	367	$0	1,101	D
Restricted Stock Unit	(11)	02/14/2026		M			204	(11)	(11)	Common Stock	204	$0	0	D
Restricted Stock Unit	(12)	02/14/2026		M			220	(12)	(12)	Common Stock	220	$0	220	D
Restricted Stock Unit	(13)	02/14/2026		M			301	(13)	(13)	Common Stock	301	$0	602	D

Explanation of Responses:

1. Includes a total of 21 shares purchased under the Issuer Employee Stock Purchase Plan ('ESPP') on September 30, 2025 and December 31, 2025. There are a total of 252.944 shares held in the ESPP which has been increased by 0.005 shares due to a rounding calculation of previously issued fractional shares.

2. Represents Restricted Stock Units ('RSU') that were granted on February 14, 2025, were deferred in accordance with the Issuer's Deferred Compensation Plan and have vested. Upon vesting, these RSUs were recorded in an account under such Plan and represents a contingent right to receive one share of Issuer common stock that is payable as soon as practicable after the reporting person's termination of employment with the Issuer.

3. Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026.

4. Includes 367 vested but deferred RSUs.

5. Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.

6. Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027.

7. Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030.

8. Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2027.

9. Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in three annual installments, beginning February 14, 2027.

10. Represents RSUs that were granted on February 14, 2025 and deferred in accordance with the Issuer's Deferred Compensation Plan and represents a contingent right to receive one share of Issuer common stock vesting in four annual installments, beginning February 14, 2026. Upon vesting, each such RSU will be recorded in an account under such Plan.

11. Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments, beginning February 14, 2023.

12. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.

13. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.

Remarks:

	/s/ Lily J. Lu, Attorney-in-Fact for Michael Lane	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did IDEXX (IDXX) executive Michael Lane report?

Michael Lane reported equity compensation activity, including new option and RSU grants plus RSU vesting into common stock. The filing also shows a small share disposition used to cover tax obligations tied to these awards, rather than an open-market sale.

How many stock options did Michael Lane receive in this IDEXX (IDXX) Form 4?

Lane received 5,361 non-qualified stock options and 162 incentive stock options. Footnotes state these options become exercisable in scheduled installments starting February 14, 2027 and February 14, 2030, reflecting long-term, time-based vesting rather than immediately exercisable options.

What restricted stock unit (RSU) grants were disclosed for IDEXX (IDXX) executive Michael Lane?

The filing shows new RSU grants of 1,262 and 1,620 units. Footnotes explain these RSUs will vest in annual installments beginning February 14, 2027 and be deferred into the company’s Deferred Compensation Plan, each ultimately representing one share of IDEXX common stock.

Did Michael Lane sell IDEXX (IDXX) shares in the open market?

The Form 4 shows a 221‑share disposition coded “F,” meaning shares were withheld to pay taxes at a price of $629.35. This represents a tax-withholding transaction, not a discretionary open-market sale of IDEXX common stock by the executive.

How many IDEXX (IDXX) common shares does Michael Lane now hold directly?

After the reported RSU conversions and tax-withholding disposition, Michael Lane directly holds 8,023.944 shares of IDEXX common stock. This figure reflects only his direct ownership and excludes indirect shares held in his spouse’s IRA account.

What indirect IDEXX (IDXX) holdings related to Michael Lane are disclosed?

The Form 4 reports 592 IDEXX common shares held indirectly in an IRA owned by Lane’s spouse. A footnote states he disclaims beneficial ownership of those shares, except to the extent of any pecuniary interest he may have in the account.